Cetera Investment Advisers Raises Stock Holdings in Tempus AI, Inc. $TEM

Cetera Investment Advisers boosted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 18.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 32,417 shares of the company’s stock after buying an additional 5,123 shares during the quarter. Cetera Investment Advisers’ holdings in Tempus AI were worth $2,060,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. PNC Financial Services Group Inc. raised its stake in shares of Tempus AI by 6.1% in the 2nd quarter. PNC Financial Services Group Inc. now owns 5,003 shares of the company’s stock valued at $318,000 after acquiring an additional 287 shares during the period. Concord Wealth Partners increased its holdings in Tempus AI by 308.0% in the 2nd quarter. Concord Wealth Partners now owns 408 shares of the company’s stock valued at $26,000 after purchasing an additional 308 shares during the last quarter. Sigma Planning Corp raised its position in Tempus AI by 1.0% in the second quarter. Sigma Planning Corp now owns 33,834 shares of the company’s stock valued at $2,150,000 after purchasing an additional 319 shares during the period. Farther Finance Advisors LLC lifted its stake in Tempus AI by 59.9% during the second quarter. Farther Finance Advisors LLC now owns 884 shares of the company’s stock worth $56,000 after purchasing an additional 331 shares in the last quarter. Finally, Allworth Financial LP boosted its position in shares of Tempus AI by 5,000.0% during the second quarter. Allworth Financial LP now owns 459 shares of the company’s stock worth $29,000 after buying an additional 450 shares during the period. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Tempus AI Price Performance

TEM stock opened at $78.11 on Friday. The business’s 50-day moving average is $82.66 and its two-hundred day moving average is $72.60. The company has a debt-to-equity ratio of 2.45, a current ratio of 3.28 and a quick ratio of 3.12. The firm has a market capitalization of $13.90 billion, a P/E ratio of -65.63 and a beta of 4.86. Tempus AI, Inc. has a 1 year low of $31.36 and a 1 year high of $104.32.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The firm had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company’s revenue was up 84.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Insider Transactions at Tempus AI

In related news, COO Ryan Fukushima sold 10,099 shares of the firm’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $65.54, for a total transaction of $661,888.46. Following the transaction, the chief operating officer owned 829,081 shares in the company, valued at $54,337,968.74. This trade represents a 1.20% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Eric P. Lefkofsky sold 332,500 shares of the firm’s stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $89.11, for a total transaction of $29,629,075.00. Following the transaction, the chief executive officer owned 9,074,532 shares in the company, valued at approximately $808,631,546.52. This trade represents a 3.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 1,071,888 shares of company stock worth $84,144,336. 26.27% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms recently issued reports on TEM. Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. BTIG Research lifted their target price on Tempus AI from $96.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research note on Wednesday, October 8th. Needham & Company LLC raised their price objective on shares of Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Canaccord Genuity Group dropped their price objective on shares of Tempus AI from $110.00 to $95.00 and set a “buy” rating for the company in a report on Wednesday, November 5th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $80.75.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.